SYNLOGIC, INC. Common Unit, Outstanding
SYNLOGIC, INC. (SYBX) had Common Unit, Outstanding of 0 shares as of 2017-12-31, per its 10-K filed 2018-03-20.
Discontinued › Balance Sheet › Equity › Limited Liability Company (LLC) Members' Equity
us-gaap:CommonUnitOutstanding · last filed 2018-03-20
- 2017-12-31: Common Unit, Outstanding 0.00 shares.
- 2017-09-30: Common Unit, Outstanding 0.00 shares.
- 2016-12-31: Common Unit, Outstanding 1.85M shares; Common Unit, Outstanding as first filed 1.85M shares.
| Period end | Common Unit, Outstanding | Common Unit, Outstanding as first filed |
|---|---|---|
| 2017-12-31 | 0.00 shares 10-K · filed 2018-03-20 | |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-13 | |
| 2016-12-31 | 1.85M shares 10-K · filed 2018-03-20 | 1.85M shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |